Supplementary Material
Null mutants in single marker BF and ndh2 cKOs in Δnubm BF. A stitching PCR approach was employed to generate deletion constructs [6] . The constructs were designed such that drug resistance genes were flanked by regions upstream and the last 456 bp of the NDH2 CDS. First, these regions were amplified from genomic DNA using Phusion polymerase system (Thermo) with an overhang (20 bp) of the sequence from drug resistance genes (HYG, PHLEO or PAC) (primers 5-10). CDSs for the drug resistance genes were also amplified using Phusion PCR system (primers 13-16). The first round amplicons were then stitched together in by amplification using primers situated at 5' end of the 5' UTR and 3' end of the 3'UTR (primers 11 and 12). The second round amplicons were then dA-tailed using GoTaq Polymerase (Promega), and cloned into pGEM-T Easy (Promega) vector. An ectopic copy of V5 tagged NDH2 was generated by cloning the NDH2 CDS into pLew79-3V5-BSD, which was constructed by swapping the PAC gene from pLew79-NDH2-V5-PAC plasmid with the BSD gene from pLew100-V5-BSD (kind gift from George Cross) using SnaBI sites.
Initial confirmation of gene disruptions was done by PCR. Subsequent Southern analysis confirmation was performed as shown in the main text. Western blot analysis showing that after withdrawal of Tet, NDH2-V5 expression had strongly decreased by day 2 as compared to day 0, but increased again at later time points. The same blot was re-probed with anti-PGK as loading control. The samples analyzed here were derived from a repeat of the growth experiment shown in Fig. 1E . Proliferation slowed from day 1 to day 3 and then recovered to near normal rates by day 5.
